Literature DB >> 3653140

Hypercalcaemia in cerebellar medulloblastoma: pathogenesis of solid tumour-associated hypercalcaemia.

O Arisaka1, K Obinata, K Yabuta, K Ishimoto, K Sato.   

Abstract

A 7-year-old boy developed acute, severe hypercalcaemia following the partial excision of a cerebellar medulloblastoma. The serum calcium level was extremely high (19.8 mg/100 ml), but a skeletal survey revealed no apparent bone metastatic lesions; such lesions were only detected by X-ray 3 weeks after the onset of hypercalcaemia. Hypercalcaemia was promptly resolved by intravenous mithramycin administration, before which the serum parathyroid hormone level, 1,25-(OH)2-vitamin D level and the nephrogenous cyclic AMP level were low. However, the relation between serum calcium levels and urinary calcium excretions indicated that renal calcium reabsorption was increased in association with hypercalcaemia, suggesting that a parathyroid hormone-like effect was operative on the renal tubules. It is possible that a combination of increased bone resorption by metastatic tumour cells and renal tubular handling of calcium presumably mediated by tumour-produced humoral factors was responsible for the acute development of severe hypercalcaemia in this patient with medulloblastoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653140     DOI: 10.1007/BF00444958

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Extracranial metastases from central nervous system tumors in children and adolescents.

Authors:  M T Gyepes; G J D'angio
Journal:  Radiology       Date:  1966-07       Impact factor: 11.105

2.  Role of kidney in regulation of plasma-calcium.

Authors:  B E Nordin; M Peacock
Journal:  Lancet       Date:  1969-12-13       Impact factor: 79.321

3.  Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

Authors:  A F Stewart; R Horst; L J Deftos; E C Cadman; R Lang; A E Broadus
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

4.  Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

Authors:  S H Ralston; M D Gardner; F J Dryburgh; A S Jenkins; R A Cowan; I T Boyle
Journal:  Lancet       Date:  1985-10-26       Impact factor: 79.321

5.  Rat osteogenic sarcoma cells:effects of some prostaglandins, their metabolites and analogues on cyclic AMP production.

Authors:  D Atkins; T J Martin
Journal:  Prostaglandins       Date:  1977-05

6.  Extracranial metastases in childhood primary intracranial tumors. A report of 21 cases and review of the literature.

Authors:  A N Campbell; H S Chan; L E Becker; A Daneman; T S Park; H J Hoffman
Journal:  Cancer       Date:  1984-02-15       Impact factor: 6.860

7.  Mechanism of the hypocalcemic effect of mithramycin.

Authors:  D T Kiang; M K Loken; B J Kennedy
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

8.  Systemic metastases from medulloblastoma: report of two cases and review of the literature.

Authors:  G M Kleinman; F H Hochberg; E P Richardson
Journal:  Cancer       Date:  1981-11-15       Impact factor: 6.860

9.  Primary hyperparathyroidism. Case report and management.

Authors:  O Arisaka; M Arisaka; K Toyono; T Shimizu; K Yabuta; H Hayashi; Y Sugiyama; T Tanaka; R Kitagawa
Journal:  Clin Pediatr (Phila)       Date:  1985-06       Impact factor: 1.168

10.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

View more
  1 in total

Review 1.  Paraneoplastic manifestations in children.

Authors:  J H de Graaf; R Y Tamminga; W A Kamps
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.